© 2019 Vasoptic Medical Inc.

1215 E. Fort Ave Suite 304
Baltimore, MD 21230

Vasoptic Medical Closes Convertible Financing With Maryland TEDCO

November 30, 2012

 

FOR IMMEDIATE RELEASE

 

Columbia, MD (November 29, 2012)—Vasoptic Medical, Inc., a Maryland-based start-up medical device company, today announced the closing of a $75,000 convertible note with the Maryland Technology Development Corporation (TEDCO) through the Maryland Technology Transfer and Commercialization Fund (MTTCF). The funds will support the development of a low-cost, mobile solution for the early detection of diabetic retinopathy—a condition that afflicts nearly 1 in 3 diabetes patients and results in severe vision impairment and blindness.

 

“MTTCF was established to enable companies to achieve early technical milestones that are critical to move technologies further along the commercialization pathway and lead to follow-on investments,” said Rob Rosenbaum, President and Executive Director of TEDCO. “The technology being developed at Vasoptic Medical shows incredible promise and we are excited to support its development at this early stage.”

 

“We are honored to receive the support of TEDCO and the MTTCF funds, which will enable us to move our imaging technology to the clinic,” said M. Jason Brooke, MSE, JD, co-founder, COO, and VP of R&D. “Through the support of TEDCO, Vasoptic Medical will be poised to commercialize a novel mobile solution for the early diagnosis of a medical condition that significantly impacts millions of diabetics around the globe.”

 

Vasoptic Medical recently established its headquarters in Columbia, Maryland at the Howard County Economic Development Authority’s Maryland Center for Entrepreneurship.

 

* * *

 

About Vasoptic Medical, Inc.

 

Vasoptic Medical, Inc. is an early-stage, start-up company with a mission to advance healthcare through innovation in medical diagnostics. Headquartered in Columbia, Maryland, Vasoptic Medical is committed to creating and delivering value to the patient and the healthcare system.

 

For more information, please visit www.VasopticMedical.com or contact:

 

Jason Brooke, MSE, JD

COO, GC & VP of R&D

Tel: 410.730.1896

Email: Jason.Brooke@VasopticMedical.com

Share on Facebook
Share on Twitter
Please reload

Recent News

Vasoptic Medical impresses at ARVO 2017

May 30, 2017

Vasoptic Medical's $1.5 million cash infusion pushes it toward FDA approval

April 24, 2017

Title: Ophthalmic examination and disease management with multiple illumination modalities

Patent No. US9492083

Vasoptic receives another patent issuance from The United States Patent and Trademark Office (USPTO)

November 15, 2016

1/10
Please reload